Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (2010 - 2025)

Ironwood Pharmaceuticals has reported Cash from Investing Activities for 16 years, with the latest figure at $1000.0 in Q4 2025.

• Quarterly Cash from Investing Activities changed N/A year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$34000.0 (up 76.06% YoY) and the FY2025 annual result came in at -$34000.0, up 76.06% from the prior year.
• Cash from Investing Activities rose to $1000.0 in Q4 2025 per IRWD's latest filing, from -$2000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $27000.0 in Q4 2022 and troughed at -$999.5 million in Q2 2023.
• A 5-year average of -$64.2 million and a median of -$44500.0 in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities soared 121.09% in 2022, then slumped 1135686.36% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$128000.0 in 2021, then jumped by 121.09% to $27000.0 in 2022, then sank by 15611.11% to -$4.2 million in 2023, then surged by 99.62% to -$16000.0 in 2024, then surged by 106.25% to $1000.0 in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $1000.0, -$2000.0, and -$2000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.